None
Conditions
Interventions
Intake powdered symbiotic 1 for 2 weeks ,powdered symbiotic 2 for 2 weeks ,and powdered prebiotic for 2 weeks.
Sponsors
Morinaga Milk Industry Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects of both sexes aged 18 years or older and younger than 65 years.
Exclusion criteria
Exclusion criteria: 1. Subjects who regularly use medicine that affect the gut microbiota, such as intestinal regulators, laxatives, etc 2. Subjects who unable to stop ingestion of foods and supplements containing bifidobacteria, oligosaccharide, etc. 3. Subjects with serious disorders on hepatic, kidney, cardiac, lung, digestive organs, blood, endocrine system, mental and metabolic system, or related severe past medical histories 4. Subjects with medication allergy, food allergy, or serious history of these 5. Subjects who have milk allergy or lactose intolerance 6. Subjects who are pregnant, under lactation or expecting to be pregnant during this study 7. Subjects who participated in other study within 1 month prior to obtaining informed consent 8. Any candidates considered to be inappropriate for this study by the principal investigator based on their background etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Faecal micorbiota, Faecal metabolites | — |
Countries
Japan
Contacts
Public ContactKeisuke Yoshida
MORINAGA MILK INDUSTRY CO.,LTD Innovative Research Institute R&D Division
Outcome results
None listed